Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Overweight × Endocrine × Clear all

Phase

Status

Completed 8 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Lymphoid 1 Endocrine 1

Conditions

Neuroendocrine Tumors 66 Pituitary Neoplasms 45 Thyroid Cancer, Papillary 22 Multiple Endocrine Neoplasia Type 1 20 Carcinoma, Neuroendocrine 19 Pheochromocytoma 16 Paraganglioma 13 Thyroid Neoplasms 12 Neoplasm Metastasis 12 Differentiated Thyroid Cancer 12 Carcinoid Tumor 12 Adrenocortical Carcinoma 11 Neoplasms 10 Adrenal Gland Neoplasms 8 Thyroid Carcinoma, Anaplastic 7 Pancreatic Neoplasms 7 Insulinoma 7 Pituitary Diseases 6 Lung Neoplasms 6 Acromegaly 6 Stomach Neoplasms 5 Prostatic Neoplasms 5 Prolactinoma 5 Gastro-enteropancreatic neuroendocrine tumor 5 Carcinoma, Hepatocellular 5 Adenoma, Islet Cell 5 Small Cell Lung Carcinoma 4 Recurrence 4 Melanoma 4 Lymphatic Metastasis 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05319704 2022-04-08

Speed-Enso

University Hospital, Clermont-Ferrand

Phase NA Unknown

Multiple Endocrine Neoplasia Type 1, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡